Short Interest in AstraZeneca PLC (OTCMKTS:AZNCF) Declines By 28.2%

AstraZeneca PLC (OTCMKTS:AZNCF) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 320,500 shares, a drop of 28.2% from the February 28th total of 446,500 shares. Based on an average trading volume of 3,200 shares, the short-interest ratio is presently 100.2 days.

AstraZeneca Trading Down 0.1 %

OTCMKTS:AZNCF opened at $147.36 on Tuesday. AstraZeneca has a 12-month low of $120.64 and a 12-month high of $175.00. The stock has a fifty day moving average price of $146.83 and a 200 day moving average price of $142.58.

AstraZeneca Increases Dividend

The business also recently declared a dividend, which was paid on Monday, March 24th. Shareholders of record on Friday, February 21st were given a $2.10 dividend. The ex-dividend date was Wednesday, February 19th. This is a positive change from AstraZeneca’s previous dividend of $1.00. AstraZeneca’s dividend payout ratio (DPR) is currently 343.14%.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.